{
    "url_original": "https://www.wsj.com/articles/lillys-covid-19-antibody-treatment-authorized-for-use-in-children-11638568015?mod=business_lead_pos2",
    "url": "lillys-covid-19-antibody-treatment-authorized-for-use-in-children-11638568015",
    "title": "Lilly’s Covid-19 Antibody Treatment Authorized for Use in Children",
    "sub_head": "The FDA’s authorization expands the drug’s use to fight Covid-19 to people under the age of 12",
    "category_1": "Business",
    "category_2": "Health Care",
    "time": "2021-12-03 16:46:00",
    "body": "Eli Lilly  & Co.’s monoclonal antibody drug has been cleared for emergency use in children under the age of 12, the Food and Drug Administration said on Friday.<br />The authorization is the first for an antibody drug to treat young children, including newborns, who have tested positive for Covid-19 or been exposed to the virus and who are at high risk of developing severe cases including hospitalization or death."
}